Thoracic drainage devices market seen reaching $1.44 billion by 2030

The thoracic drainage devices market is projected to grow from $0.96 billion in 2025 to $1.04 billion in 2026, according to The Business Research Company, with demand rising on more thoracic surgeries, pneumothorax treatment and ICU expansion. The report says North America led the market in 2025, while smart drainage systems and remote monitoring are set to shape the next phase of growth.

Why it matters: - Thoracic drainage devices are tied to post-surgical recovery, lung re-expansion and complication management after chest procedures. - Rising demand matters because more patients are undergoing thoracic surgeries and treatment for pneumothorax, chest trauma and fluid buildup. - The market’s growth also tracks broader pressure from cardiovascular and pulmonary disease.

What happened: - The Business Research Company published its Thoracic Drainage Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on August 31, 2026. - The report puts the thoracic drainage devices market at $0.96 billion in 2025 and forecasts $1.04 billion in 2026. - The report projects the market will reach $1.44 billion by 2030. - North America was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The market posted a 8.4% CAGR in the move from $0.96 billion in 2025 to $1.04 billion in 2026. - The report says the market will grow at a 8.3% CAGR to 2030. - Past growth has been driven by more thoracic surgeries, higher demand for pneumothorax treatment, ICU expansion, better management of post-operative complications and more chest trauma cases. - Forecast growth is linked to smart drainage systems, remote patient monitoring, shorter hospital stays, advanced sensors and better surgical outcomes. - Expected product trends include digital chest drainage systems, real-time fluid monitoring, minimally invasive drainage, automated pressure regulation and portable thoracic drainage units. - Thoracic drainage devices remove air, fluid or blood from the pleural space to prevent complications such as pneumothorax or pleural effusion. - The devices typically use a chest tube connected to a collection system to support continuous drainage. - The drainage process helps lung re-expansion and reduces further complications after thoracic procedures. - The report cites rising cardiovascular and pulmonary disorders as a key growth driver. - The report links those disorders to sedentary lifestyles, unhealthy diets, smoking and poor health monitoring. - In October 2024, the Centers for Disease Control and Prevention said cardiovascular disease caused about 919,032 deaths in the US in 2023, or one in every three deaths. - The CDC data said one in six cardiovascular deaths occurred in adults younger than 65. - The report also points to growing preference for minimally invasive surgeries as a demand driver. - The American Society of Plastic Surgeons reported a 7% increase in minimally invasive procedures in 2023, outpacing traditional surgery growth by 2%.

Between the lines: - The forecast points to a shift from basic drainage hardware toward connected, sensor-driven systems. - Hospitals are looking for tools that can reduce length of stay and improve outcomes, which favors devices that support monitoring and faster recovery. - The regional lead in North America suggests mature adoption now, while future upside may come from wider global penetration.

What's next: - The market is expected to benefit from digital chest drainage, automated pressure control and portable units. - Remote monitoring and advanced sensors are likely to become more important as care moves toward earlier discharge and tighter post-operative oversight. - Emerging regions outside North America are expected to add to global growth over the forecast period.

The bottom line: - Thoracic drainage devices are moving from a stable clinical niche into a higher-growth market shaped by more surgery, more respiratory disease and more connected care.